Huawei’s Watch D2, launched in November 2024, gained great traction in China as it realized that buyers could claim their medical insurance and eliminated the need to pay out of pocket money. .
High demand
Since its launch, smartwatches have been in high demand at various pharmacies across China, with some even reporting that customers are placing pre-orders as stocks are selling out rapidly.
Also Read: NASA tracks a giant asteroid set to pass through Earth on February 12th – Is there a risk?
On Chinese social media platforms such as Xiaohongshu, users share how the blood pressure tracking feature of Huawei Watch qualifies for registration as a medical device. As a result, customers do not have to pay themselves, as costs are deducted from funds deposited in individual accounts under the state health insurance scheme. China.
See D2: Important Features
Released in China for 2,988 yuan, or $409, the Huawei smartwatch is supported by several health features such as blood pressure, heart rate, steps count, and sleep quality. This makes it eligible as a medical device under the Chinese insurance system.
“Watches are currently unavailable. The Shanghai-based pharmacy told local media.
Among its popularity, Shanghai pharmacies even limit purchases through medical insurance for one person per person, but many people activate it to buyers at the time of purchase to prevent resale. I’m asking for it.
Huawei called the D2 watch “wrist blood pressure recorder.”
China’s medical insurance program
The country’s health insurance program, which covers nearly 95% of China’s 1.4 billion people, returns a certain portion of their monthly money to people’s individual accounts.
People can use this money to pay for their medicine along with medical devices such as blood pressure monitors, thermometers, and glucometers purchased from hospitals and pharmacies.
Also Read: Donald Trump’s tariffs target European automakers as they strengthen US trade war
However, this money cannot be used for any other purpose.
China’s apple
Despite its advanced health tracking capabilities, Apple smartwatches are not registered as Chinese medical devices. This means that customers have to pay from their pocket.
But Huawei’s latest move has sparked controversy, raising concerns about the possibility that high-tech companies will use medical labeling, putting an additional burden on the country’s healthcare resources.
FAQ
1. What is the market share of Huawei and Apple smartwatches in China?
According to Benzinga, Huawei led the shipment of smartwatches in the first three quarters of 2024, gaining a market share of 16.9%, with Apple continuing closely at 16.2%.
2. What are the prices and important features of the Huawei Watch D2?
The price of the Huawei watch D2 is 2,988 yuan ($409) in China. It provides features such as blood pressure monitoring, heart rate tracking, step counting, and sleep quality analysis.
Disclaimer Statement: This content is written by a third party. The views expressed here are those of the respective authors/organizations and do not represent views from the economic era (ET). ET is not responsible for, warrants, approves, or in any way. Take all the steps required to ensure that the information and content provided is correct, updated and verified. ET disclaims all warranties, express or implied, relating to the Report and the content therein.
